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 Intrinsic renal cytoprotective antioxidant 
factors and protein responses exist to 
maintain reactive oxygen species (ROS) 
balance. Th e cytoprotective antioxidant 
proteins include superoxide dismutases 
that convert superoxide into hydrogen 
peroxide (H 2 O 2 ), which in turn is ren-
dered inactive by catalase and glutath-
ione peroxide. In a study by Godin  et al. 1 
(this issue), mice transgenically express-
ing catalase in the renal proximal tubular 
cells (referred to as Cat-Tg) were used. 
Catalase is capable of breaking down 
H 2 O 2 and is an important factor in the 
prevention of tissue damage by oxidative 
stress. Previously, the authors used the 
same Cat-Tg mice to show that resistance 
to H 2 O 2 -induced renal damage resulting 
from diabetes is due to alleviation of 
some of the oxidative stress caused by 
this condition. 2 
 In the study by Godin  et al. , 1 the trans-
genic mice were crossed with a mouse 
transgenically expressing angiotensino-
gen in the renal proximal tubular cells 
(referred to as Agt-Tg) in an eff ort to 
 elucidate whether overexpression of 
catalase in these cells can reverse the 
pathological changes that arise in Agt-
Tg mouse kidneys. To generate angi-
otensin II locally, the kidneys must 
contain all the necessary substrates and 
synthetic and modifying enzymes. Angi-
otensinogen is required for the forma-
tion of all  angiotensin peptides. 
Increased expression of angiotensinogen 
leads to augmented local production of 
angiotensin II, a pathway that leads to 
proliferative and fibrotic injury, and 
ultimately to progression of chronic kid-
ney disease. Supporting this notion, 
Agt-Tg mice were shown to have ele-
vated blood pressure, increased oxida-
tive stress, and increased albuminuria, 
among other problems. 3,4 
 Godin  et al. 1 showed that coexpression 
of catalase ameliorates the albuminuria, 
elevated blood pressure, interstitial fi bro-
sis, tubular-cell apoptosis, and ROS char-
acteristic of the Agt-Tg strain. Th is is in 
line with observations that catalase defi -
ciency in mice renders kidneys more 
prone to oxidative stress. 5 Th ese fi ndings 
are indicative of a protective role for 
catalase and underscore the importance 
of the intrarenal renin – angiotensin 
system (RAS) in the development of 
these conditions. 
 In Agt-Tg mice, intrarenal angioten sin 
II concentration may be increased, while 
increased ROS production may lead to 
the development of hypertension, tubu-
lar fibrosis, and apoptosis ( Figure 1 ). 
Moreover, several  in vitro studies have 
provided evidence that ROS promote 
angiotensinogen expression in proximal 
tubular cells. Th ese data raise the possi-
bility that the activated ROS – angi-
otensinogen – RAS axis plays a critical 
role in the progression of chronic kidney 
disease. Contributions of the intrarenal 
RAS and ROS to the progression of 
chronic kidney disease have been shown 
in a number of human studies. 6 – 8 Of 
particular relevance to the article by 
Godin  et al. , 1 these Agt / Cat-Tg studies 
demonstrate that H 2 O 2 reduction 
by catalase appears to be capable of 
reducing intrarenal RAS activation, 
subsequently normalizing blood 
pressure and decreasing tubular dam-
age, including apoptosis. 
 Th e molecular mechanisms by which 
the intrarenal RAS enhances renal prox-
imal tubular-cell apoptosis in Agt-Tg 
mice have yet to be determined. In the 
study by Godin  et al. , 1 conditional trans-
genic mice overexpressing catalase in 
proximal renal tubular cells manifested 
attenuated tubular apoptosis and proap-
optotic gene expression. Th ese results 
clearly show that catalase played a critical 
role in the protection of renal tubular 
cells against apoptosis. 
 The data of Godin  et al. 1 show that 
higher urinary excretion levels of angio-
tensin II and lower excretion levels of 
angiotensin 1 – 7 (Ang 1 – 7) were observed 
in Agt-Tg compared with non-Tg mice. 
Th ey also show that angiotensin-convert-
ing enzyme (ACE) activity was increased 
and ACE2 expression was decreased in 
Agt-Tg mice. In Agt / Cat-Tg mice, ACE 
activity and renal ACE2 expression were 
completely normalized, suggesting that 
H 2 O 2 produced with proximal tubule cells 
increases ACE activity and decreases 
ACE2 expression. However, the underly-
ing mechanisms of H 2 O 2 upregulation 
with ACE activity have yet to be defi ned. 
Th e new information that can be gained 
from the study by Godin  et al. 1 is that the 
increase in ACE activity and reduction in 
renal tubular ACE2 expression are related 
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to high blood pressure and tubular 
 damage, while the reduction in ACE activ-
ity and normalization of ACE2 expression 
are related to inhibition of tubular fi brosis 
and apoptosis. However, recently, the 
importance of ACE2 in kidney disease 
and hypertension has been determined. 9 
Godin  et al. measured urinary excretion 
of angiotensin II and Ang 1 – 7. 1 If the 
urinary excretion ratio of angiotensin II 
to Ang 1 – 7 could be measured in chronic 
kidney disease patients, it would be a 
powerful tool for monitoring ACE1 –
 ACE2 balance in the kidneys and thus 
would be useful in patient treatment. 
Since ACE2 degrades the vasoactive and 
proliferative peptide angiotensin II, 
modifi cation of ACE2 levels by stimula-
tion of expression or exogenous admin-
istration of ACE2 may provide a 
therapeutic approach in various kidney 
diseases. Catalase may be one of the can-
didate factors. In this regard, experimen-
tal studies are urgently needed to further 
delineate the benefi cial eff ects of increased 
ACE2 expression on renal damage. 
 In a previous report using apocynin, 4 
blood pressure in Agt-Tg mice did not 
decrease with apocynin treatment. In the 
study by Godin  et al. , 1 however, blood 
pressure in Agt-Tg mice was decreased 
to control levels by crossing with Cat-Tg 
mice. Catalase overexpression probably 
alleviates oxidative stress regardless of 
its source, whereas apocynin appears to 
infl uence only NADPH oxidase-depend-
ent ROS production. If so, it is possible 
that the catalase-induced reduction in 
H 2 O 2 may be eff ective in blood pressure 
reduction. However, Cat-Tg mice did 
not show hypotension, and moreover, 
the catalase-defi cient mice did not show 
hypertension. 5 Th us, intrarenal H 2 O 2 
may not be related to blood pressure in 
a steady state. Godin  et al. 1 provide a 
possible explanation in suggesting that 
renal angio tensin II may aff ect blood 
pressure through direct vasoconstriction 
of glomerular arterioles via the angio-
tensin II type 1 receptor independently 
of ROS generation. However, if renal 
angio tensin II aff ects direct vasocon-
striction of glomerular arterioles, the 
glomerular filtration rate should be 
aff ected by glomerular vasoconstriction. 
However, glomerular volume did not 
diff er signifi cantly between Tg and non-
Tg mice and was unaff ected by catalase 
overexpression; there were no data for 
glomerular fi ltration rate or serum cre-
atinine. More investigations are there-
fore needed to clarify this mechanism 
further. 
 ROS can activate several proinfl amma-
tory transcription factors, resulting in the 
production of cytokines, chemokines, 
and vascular adhesion molecules and, 
subsequently, the infl ux of infl ammatory 
cells into the kidneys. Godin  et al. also 
demonstrated that Agt gene expression 
and ROS, especially H 2 O 2 generation, are 
also important in mediating tubulointer-
stitial fibrosis. 1 They showed that the 
expression of collagen type IV, transform-
ing growth factor-  1, plasminogen acti-
vator inhibitor-1, and monocyte 
chemotactic protein-1 was enhanced in 
Agt-Tg kidneys but normalized in Agt /
 Cat-Tg kidneys. Intrarenal angiotensin II, 
generated from local angiotensinogen 
and renin and ACE activity, exerts multi-
ple eff ects on the kidneys, promoting pro-
gression of renal injury. Such injury 
includes an increase in glomerular capil-
lary pressure, induction of profi brotic and 
proinfl ammatory cytokines, promotion 
of infl ammatory-cell infi ltration, stimula-
tion of cell proliferation and hypertrophy, 
and upregulation of extracellular matrix 
synthesis. Many previous studies have 
shown that reduction in ROS is benefi cial 
for prevention of tubular fi brosis. How-
ever, the data of Godin  et al. 1 showing 
that tubular damage in Agt-Tg mouse 
kidneys is completely inhibited in Agt /
 Cat-Tg mice suggest that endogenous 
catalase overexpression may be critical 
for renal protection from RAS-activated 
injury. For treatment of chronic kidney 
disease patients, upregulation of endog-
enous cytoprotective proteins targeted to 
or generated in the kidneys may function 
more effi  ciently than exogenously added 
antioxidants, since they act within the cell 
or cellular compartment where ROS are 
actually generated. 
 Lastly, the authors also discuss tubular 
hypoxia. 1 The renal proximal tubular 
cells in Cat-Tg mice may have an abun-
dant oxygen supply, especially under an 
oxidative stress-rich environment, since 
catalase changes H 2 O 2 into oxygen and 
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 Figure 1  |  Assumed renoprotective effects of catalase in chronic kidney disease. On the basis 
of the work by Godin  et al. , 1 it is suggested that the intrarenal RAS is activated by upregulation of 
angiotensinogen. This is followed by secondary intrarenal ROS generation through an increase in 
NADPH oxidase, leading to the development of hypertension, tubular fibrosis, and apoptosis. The 
effectiveness of catalase may result from not only ROS blockade but also hypoxia improvement, 
suggesting its usefulness in preventing chronic kidney disease progression. ACE, angiotensin-
converting enzyme; Ang 1 – 7, angiotensin 1 – 7; PAI-1, plasminogen activator inhibitor-1; RAS, 
renin – angiotensin system; ROS, reactive oxygen species; TGF-  1, transforming growth factor-  1. 
commentar y
1062   Kidney International (2010) 77 
water. Cat-Tg mice therefore exhibit 
reduction of not only H 2 O 2 but also oxy-
gen supply ( Figure 1 ). Chronic hypoxia 
in the tubulointerstitium is one of the 
main mechanisms of interstitial fi brosis 
and a final common pathway to end-
stage renal failure. 10 Hypoxia of tubular 
cells leads to apoptosis or epithelial – mes-
enchymal transdiff erentiation, which in 
turn exacerbates fi brosis of the kidneys 
and subsequent chronic hypoxia, setting 
in motion a vicious cycle. Angiotensin II, 
which is produced in Agt-Tg mouse kid-
neys, may not only constrict efferent 
arterioles but, via the induction of oxida-
tive stress, also hamper the effi  cient uti-
lization of oxygen in tubular cells. Th e 
main mechanism of improvement 
observed in Agt / Cat-Tg mice may there-
fore be inhibition of tissue hypoxia 
through increased oxygen supply from 
H 2 O 2 . Th erapeutic approaches that target 
chronic hypoxia should thus prove eff ec-
tive against a broad range of renal diseases. 
Th e observational study by Godin  et al. 1 
may off er new insights into a novel thera-
peutic approach focusing on catalase. 
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